table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 outpatients
Immunostimulants drugs
convalescent plasma treatment CONV-ERT CoV-Early ... C3PO
Early convalescent plasma. CoV-Early ...
interferon
peginterferon Feld
neutralizing antibody
bamlanivimab monotherapy BLAZE-1 phase 2 ...
bamlanivimab/etesevimab BLAZE-1 phase 2 ... BLAZE-1 phase 3 ...
casirivimab/imdevimab (Ronapreve) Cov-2067 Weinreich ... Cov-2069 ...
sotrovimab (Xevudy; VIR-7831) COMET-ICE

1 studies excluded by filtering options 0

6708 Webb, 2021 0130selection pending

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons